Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy

Applied Radiation and Isotopes

Volumn 67, Issue 7-8 SUPPL., 2009, Pages

  Fujimoto, T ^a   Ichikawa, H ^b   Akisue, T ^c   Fujita, I ^a   Kishimoto, K ^c   Hara, H ^c   Imabori, M ^a   Kawamitsu, H ^c   Sharma, P ^d   Brown, S C ^d   Moudgil, B M ^d   Fujii, M ^c   Yamamoto, T ^e   Kurosaka, M ^c   Fukumori, Y ^b  

^a HYOGO CANCER CENTER   (Japan)

^b KOBE GAKUIN UNIVERSITY   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF FLORIDA   (United States)

^e KAGAWA UNIVERSITY   (Japan)

Author keywords

Chitosan; Enhanced magnetic resonance imaging (MRI); Gadolinium NCT; GD DTPA; Malignant fibrosis histiocytoma (MFH); Nanoparticle

Indexed keywords

ADVERSE EFFECT; AQUEOUS SOLUTIONS; CHITOSAN NANOPARTICLES; CONTRAST MEDIUM; ENHANCED MAGNETIC RESONANCE IMAGING (MRI); GAIN INSIGHT; GD-DTPA; ICP-AES; IN-CELL; INDUCTIVELY COUPLED PLASMA ATOMIC EMISSIONS; LONGITUDINAL RELAXATION TIME; MALIGNANT FIBROSIS HISTIOCYTOMA (MFH); MALIGNANT FIBROUS HISTIOCYTOMA; MRI CONTRAST AGENTS; NEUTRON CAPTURE THERAPY; SARCOMA CELLS; SIGNAL INTENSITIES; SPIN-ECHO METHODS; THERAPEUTIC POTENTIALS;

CELL CULTURE; CHITIN; CHITOSAN; CONTRAST MEDIA; INDUCTIVELY COUPLED PLASMA; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; PELLETIZING;

GADOLINIUM;

CHITOSAN; CONTRAST MEDIUM; GADOLINIUM PENTETATE; NANOPARTICLE;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; CALCULATION; CANCER CELL CULTURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; MALIGNANT FIBROUS HISTIOCYTOMA; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL; SARCOMA CELL; TUBE;

CELL LINE, TUMOR; CHITOSAN; CONTRAST MEDIA; GADOLINIUM; GADOLINIUM DTPA; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; NEUTRON CAPTURE THERAPY; PHANTOMS, IMAGING;

EID: 67649606915     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.03.063     Document Type: Article

References (13)

1. Akine Y., et al. Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy. Jpn. J. Cancer Res. 84 (1993) 841-843
2. Car D.H., et al. Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet 1 (1984) 484-486
3. De Stasio G., et al. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Res. 61 (2001) 4272-4277
4. Elster A.D., Sobol W.T., and Hinson W.H. Pseudolayering of Gd-DTPA in the urinary bladder. Radiology 174 (1990) 379-381
5. Garber D.I., and Kinsey R.R.H. Neutron Cross Sections Report. BNl-325. third ed (1976), Brookhaven National Laboratory, New York
6. Hofmann B., et al. Gadolinium neutron capture therapy of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent gadobutrol. Invest. Radiol. 34 (1999) 126-133
7. Locher G.L. Biological effects and therapeutical possibilities of neutrons. Am. J. Roentgenol. Radium Ther. 36 (1936) 1-13
8. Mishima Y., et al. New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial. Pigm. Cell Res. 2 (1989) 226-234
9. Shikata F., et al. In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur. J. Pharm. Biopharm. 53 (2002) 57-63
10. Tokumitsu H., Ichikawa H., and Fukumori Y. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm. Res. 16 (1999) 1830-1835
11. Tokumitsu H., et al. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett. 150 (2000) 177-182
12. van der Woude H.J., et al. Musculoskeletal tumors: dose fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization?. Radiology 208 (1998) 821-828
13. Weinmann H.J., et al. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am. J Roentgenol. 142 (1984) 619-624